Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation

References

• Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 2010; 62:1156-66; PMID:20828588; http://dx.doi.org/10.1016/j.addr.2010.08.010
   PubMed Web of Science ®Google Scholar
• DeLaForest A, Nagaoka M, Si-Tayeb K, Noto FK, Konopka G, Battle MA, Duncan SA. HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development 2011; 138:4143-53; PMID:21852396; http://dx.doi.org/10.1242/dev.062547
   PubMed Web of Science ®Google Scholar
• Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K, Daigo K, Ohashi R, Sugai M, Ikegame C, et al. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol 2006; 208:662-72; PMID:16400631; http://dx.doi.org/10.1002/path.1928
   PubMed Web of Science ®Google Scholar
• Hang H, Yu Y, Wu N, Huang Q, Xia Q, Bian J. Induction of highly functional hepatocytes from human umbilical cord mesenchymal stem cells by HNF4alpha transduction. PloS one 2014; 9:e104133; PMID:25137413; http://dx.doi.org/10.1371/journal.pone.0104133
   PubMedGoogle Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. The Lancet 2003; 362:1907-17; PMID:14667750; http://dx.doi.org/10.1016/S0140-6736(03)14964-1
   PubMed Web of Science ®Google Scholar
• Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Annal Surg 2006; 243:229-35; PMID:16432356; http://dx.doi.org/10.1097/01.sla.0000197706.21803.a1
   PubMed Web of Science ®Google Scholar
• Bayo J, Marrodan M, Aquino JB, Silva M, Garcia MG, Mazzolini G. The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma. Liver Int 2014; 34:330-42; PMID:24112437; http://dx.doi.org/10.1111/liv.12338
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454:436-44; PMID:18650914; http://dx.doi.org/10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem cells 2007; 25:2886-95; PMID:17690177; http://dx.doi.org/10.1634/stemcells.2007-0417
   PubMed Web of Science ®Google Scholar
• Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008; 1229:233-48; PMID:18634757; http://dx.doi.org/10.1016/j.brainres.2008.06.087
   PubMed Web of Science ®Google Scholar
• Saandi T, Baraille F, Derbal-Wolfrom L, Cattin AL, Benahmed F, Martin E, Cardot P, Duclos B, Ribeiro A, Freund JN, et al. Regulation of the tumor suppressor homeogene Cdx2 by HNF4alpha in intestinal cancer. Oncogene 2013; 32:3782-8; PMID:22986531; http://dx.doi.org/10.1038/onc.2012.401
   PubMed Web of Science ®Google Scholar
• Ning BF, Ding J, Liu J, Yin C, Xu WP, Cong WM, Zhang Q, Chen F, Han T, Deng X, et al. Hepatocyte nuclear factor 4alpha-nuclear factor-kappaB feedback circuit modulates liver cancer progression. Hepatology 2014; 60:1607-19; PMID:24752868; http://dx.doi.org/10.1002/hep.27177
   PubMed Web of Science ®Google Scholar
• Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 2010; 70:7640-51; PMID:20876809; http://dx.doi.org/10.1158/0008-5472.CAN-10-0824
   PubMed Web of Science ®Google Scholar
• Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, et al. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011; 147:1233-47; PMID:22153071; http://dx.doi.org/10.1016/j.cell.2011.10.043
   PubMed Web of Science ®Google Scholar
• Hodgkinson CP, Gomez JA, Mirotsou M, Dzau VJ. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 2010; 21:1513-26; PMID:20825283; http://dx.doi.org/10.1089/hum.2010.165
   PubMed Web of Science ®Google Scholar
• Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B, Marini FC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 2008; 10:657-67; PMID:18985472; http://dx.doi.org/10.1080/14653240802486517
   PubMed Web of Science ®Google Scholar
• Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007; 67:6304-13; PMID:17616689; http://dx.doi.org/10.1158/0008-5472.CAN-06-4024
   PubMed Web of Science ®Google Scholar
• Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, Hou JL, Deng X, Zhang JP, Han ZG, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 2008; 48:1528-39; PMID:18925631; http://dx.doi.org/10.1002/hep.22510
   PubMed Web of Science ®Google Scholar
• Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer research 2005; 65:7554-60; PMID:16140917; http://dx.doi.org/10.1158/0008-5472.CAN-05-1317
   PubMed Web of Science ®Google Scholar
• Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S, Garcia de Herreros A, Bonilla F, Munoz A. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 2005; 24:1098-103; PMID:15592505; http://dx.doi.org/10.1038/sj.onc.1208303
   PubMed Web of Science ®Google Scholar
• Kozinski K, Dobrzyn A. [Wnt signaling pathway–its role in regulation of cell metabolism]. Postepy Hig Med Dosw 2013; 67:1098-108; PMID:24379251; http://dx.doi.org/10.5604/17322693.1077719
   PubMed Web of Science ®Google Scholar
• Jiang GX, Liu W, Cui YF, Zhong XY, Tai S, Wang ZD, Shi YG, Li CL, Zhao SY. Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma. Digest Dis Sci 2010; 55:2838-43; PMID:20033841; http://dx.doi.org/10.1007/s10620-009-1099-3
   PubMed Web of Science ®Google Scholar
• Huang CL, Liu D, Ishikawa S, Nakashima T, Nakashima N, Yokomise H, Kadota K, Ueno M. Wnt1 overexpression promotes tumour progression in non-small cell lung cancer. Eur J Cancer 2008; 44:2680-8; PMID:18790633; http://dx.doi.org/10.1016/j.ejca.2008.08.004
   PubMed Web of Science ®Google Scholar
• Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res 2001; 61:3245-9; PMID:11309273
   PubMed Web of Science ®Google Scholar
• Bai XL, Zhang Q, Ye LY, Liang F, Sun X, Chen Y, Hu QD, Fu QH, Su W, Chen Z, et al. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/beta-catenin signaling. Oncogene 2015; 34:4089-97; PMID:25328135; http://dx.doi.org/10.1038/onc.2014.337
   PubMed Web of Science ®Google Scholar
• Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol 2013; 59:1107-17; PMID:23835194; http://dx.doi.org/10.1016/j.jhep.2013.07.001
   PubMed Web of Science ®Google Scholar
• Chen L, Li M, Li Q, Wang CJ, Xie SQ. DKK1 promotes hepatocellular carcinoma cell migration and invasion through beta-catenin/MMP7 signaling pathway. Mol Cancer 2013; 12:157; PMID:24325363; http://dx.doi.org/10.1186/1476-4598-12-157
   PubMed Web of Science ®Google Scholar
• Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A, Kew MC, Trepo C, Wands JR. Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 2004; 127:1110-22; PMID:15480989; http://dx.doi.org/10.1053/j.gastro.2004.07.009
   PubMed Web of Science ®Google Scholar
• Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 2009; 5:100-7; PMID:19125156; http://dx.doi.org/10.1038/nchembio.137
   PubMed Web of Science ®Google Scholar
• Proffitt KD, Madan B, Ke Z, Pendharkar V, Ding L, Lee MA, Hannoush RN, Virshup DM. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Cancer Res 2013; 73:502-7; PMID:23188502; http://dx.doi.org/10.1158/0008-5472.CAN-12-2258
   PubMed Web of Science ®Google Scholar
• Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martinez-Anso E, Prieto J, Qian C. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res 2009; 69:6951-9; PMID:19690140; http://dx.doi.org/10.1158/0008-5472.CAN-09-0541
   PubMed Web of Science ®Google Scholar
• Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Gen 2004; 36:417-22; PMID:15034581; http://dx.doi.org/10.1038/ng1330
   PubMed Web of Science ®Google Scholar
• Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y. Silibinin inhibits Wnt/beta-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 2012; 24:2291-6; PMID:22820499; http://dx.doi.org/10.1016/j.cellsig.2012.07.009
   PubMed Web of Science ®Google Scholar
• Lu W, Lin C, Roberts MJ, Waud WR, Piazza GA, Li Y. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/beta-catenin pathway. PloS One 2011; 6:e29290; PMID:22195040; http://dx.doi.org/10.1371/journal.pone.0029290
   PubMed Web of Science ®Google Scholar